PL3405197T3 - Zastosowanie delgocytynibu w leczeniu przewlekłego wyprysku dłoni - Google Patents
Zastosowanie delgocytynibu w leczeniu przewlekłego wyprysku dłoniInfo
- Publication number
- PL3405197T3 PL3405197T3 PL17701828.0T PL17701828T PL3405197T3 PL 3405197 T3 PL3405197 T3 PL 3405197T3 PL 17701828 T PL17701828 T PL 17701828T PL 3405197 T3 PL3405197 T3 PL 3405197T3
- Authority
- PL
- Poland
- Prior art keywords
- delgocitinib
- treatment
- hand eczema
- chronic hand
- chronic
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Storage Of Fruits Or Vegetables (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP16152215 | 2016-01-21 | ||
| PCT/EP2017/051133 WO2017125523A1 (en) | 2016-01-21 | 2017-01-20 | Treatment of hand eczema |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL3405197T3 true PL3405197T3 (pl) | 2024-02-12 |
Family
ID=55236207
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL17701828.0T PL3405197T3 (pl) | 2016-01-21 | 2017-01-20 | Zastosowanie delgocytynibu w leczeniu przewlekłego wyprysku dłoni |
Country Status (30)
| Country | Link |
|---|---|
| US (2) | US20200397787A1 (pl) |
| EP (2) | EP4257205A3 (pl) |
| JP (1) | JP6929860B2 (pl) |
| KR (2) | KR20180102662A (pl) |
| CN (3) | CN108472297A (pl) |
| AU (3) | AU2017209932A1 (pl) |
| BR (1) | BR112018014769A2 (pl) |
| CA (1) | CA3010547A1 (pl) |
| DK (1) | DK3405197T3 (pl) |
| ES (1) | ES2963784T3 (pl) |
| FI (2) | FI3405197T3 (pl) |
| FR (1) | FR24C1053I2 (pl) |
| HR (1) | HRP20231448T1 (pl) |
| HU (2) | HUE064192T2 (pl) |
| IL (4) | IL313543A (pl) |
| LT (2) | LT3405197T (pl) |
| MX (2) | MX394358B (pl) |
| NL (1) | NL301306I2 (pl) |
| NO (1) | NO2024058I1 (pl) |
| PL (1) | PL3405197T3 (pl) |
| PT (1) | PT3405197T (pl) |
| RS (1) | RS64798B1 (pl) |
| RU (1) | RU2018130097A (pl) |
| SG (2) | SG11201805394QA (pl) |
| SI (1) | SI3405197T1 (pl) |
| SM (1) | SMT202300415T1 (pl) |
| TW (2) | TWI783921B (pl) |
| UA (1) | UA123780C2 (pl) |
| WO (1) | WO2017125523A1 (pl) |
| ZA (1) | ZA201804098B (pl) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG11202110777XA (en) * | 2019-05-15 | 2021-11-29 | Leo Pharma As | Treatment of cutaneous lupus erythematosus |
| JP2024505910A (ja) * | 2021-02-02 | 2024-02-08 | ファイザー・インク | 慢性手湿疹の処置のための投与レジメン |
| EP4376844A1 (en) * | 2021-07-30 | 2024-06-05 | Eli Lilly and Company | Treatment of hand eczema with baricitinib |
| CN121175050A (zh) | 2023-03-17 | 2025-12-19 | 利奥药品公司 | 用于治疗患有中度至重度慢性手部湿疹的患者的慢性手部湿疹的方法 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI466885B (zh) | 2009-07-31 | 2015-01-01 | Japan Tobacco Inc | 含氮螺環化合物及其醫藥用途 |
| WO2012071654A1 (en) * | 2010-11-30 | 2012-06-07 | Bio-K Plus International Inc. | Treatment and prevention of eczema |
| US20140343034A1 (en) * | 2013-04-25 | 2014-11-20 | Japan Tobacco Inc. | Skin barrier function improving agent |
-
2017
- 2017-01-20 MX MX2018008449A patent/MX394358B/es unknown
- 2017-01-20 WO PCT/EP2017/051133 patent/WO2017125523A1/en not_active Ceased
- 2017-01-20 CN CN201780006075.2A patent/CN108472297A/zh active Pending
- 2017-01-20 HR HRP20231448TT patent/HRP20231448T1/hr unknown
- 2017-01-20 IL IL313543A patent/IL313543A/en unknown
- 2017-01-20 PT PT177018280T patent/PT3405197T/pt unknown
- 2017-01-20 UA UAA201808829A patent/UA123780C2/uk unknown
- 2017-01-20 IL IL297379A patent/IL297379A/en unknown
- 2017-01-20 SG SG11201805394QA patent/SG11201805394QA/en unknown
- 2017-01-20 RU RU2018130097A patent/RU2018130097A/ru unknown
- 2017-01-20 EP EP23195420.7A patent/EP4257205A3/en active Pending
- 2017-01-20 LT LTEPPCT/EP2017/051133T patent/LT3405197T/lt unknown
- 2017-01-20 SI SI201731440T patent/SI3405197T1/sl unknown
- 2017-01-20 US US16/071,209 patent/US20200397787A1/en not_active Abandoned
- 2017-01-20 TW TW106102111A patent/TWI783921B/zh active
- 2017-01-20 KR KR1020187024112A patent/KR20180102662A/ko not_active Ceased
- 2017-01-20 RS RS20231010A patent/RS64798B1/sr unknown
- 2017-01-20 JP JP2018538167A patent/JP6929860B2/ja active Active
- 2017-01-20 TW TW111141449A patent/TWI841027B/zh active
- 2017-01-20 DK DK17701828.0T patent/DK3405197T3/da active
- 2017-01-20 EP EP17701828.0A patent/EP3405197B1/en active Active
- 2017-01-20 FI FIEP17701828.0T patent/FI3405197T3/fi active
- 2017-01-20 KR KR1020257019206A patent/KR20250088666A/ko active Pending
- 2017-01-20 CA CA3010547A patent/CA3010547A1/en active Pending
- 2017-01-20 HU HUE17701828A patent/HUE064192T2/hu unknown
- 2017-01-20 CN CN202311350781.2A patent/CN117159553A/zh active Pending
- 2017-01-20 AU AU2017209932A patent/AU2017209932A1/en not_active Abandoned
- 2017-01-20 SM SM20230415T patent/SMT202300415T1/it unknown
- 2017-01-20 PL PL17701828.0T patent/PL3405197T3/pl unknown
- 2017-01-20 IL IL320757A patent/IL320757A/en unknown
- 2017-01-20 BR BR112018014769-9A patent/BR112018014769A2/pt not_active Application Discontinuation
- 2017-01-20 SG SG10202006830WA patent/SG10202006830WA/en unknown
- 2017-01-20 ES ES17701828T patent/ES2963784T3/es active Active
- 2017-01-20 CN CN202311350784.6A patent/CN117159554A/zh active Pending
-
2018
- 2018-06-18 IL IL260094A patent/IL260094A/en unknown
- 2018-06-19 ZA ZA2018/04098A patent/ZA201804098B/en unknown
- 2018-07-09 MX MX2022005915A patent/MX2022005915A/es unknown
-
2022
- 2022-07-08 US US17/811,347 patent/US20230138114A1/en active Pending
- 2022-10-13 AU AU2022252766A patent/AU2022252766B2/en active Active
-
2024
- 2024-11-28 AU AU2024266962A patent/AU2024266962A1/en active Pending
- 2024-12-13 NL NL301306C patent/NL301306I2/nl unknown
- 2024-12-13 NO NO2024058C patent/NO2024058I1/no unknown
- 2024-12-15 FR FR24C1053C patent/FR24C1053I2/fr active Active
- 2024-12-17 HU HUS2400045C patent/HUS2400045I1/hu unknown
- 2024-12-17 LT LTPA2024538C patent/LTPA2024538I1/lt unknown
- 2024-12-19 FI FIC20240048C patent/FIC20240048I1/fi unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL279752B (en) | Polycyclic compounds and use thereof in the treatment of immune disorders | |
| IL283086A (en) | Use of cannabidiol in the treatment of tuberous sclerosis complex | |
| HUS2500039I1 (hu) | Elafibranor primer biliáris cirrózis kezelésében történõ alkalmazásra | |
| HUE061761T2 (hu) | Tetrahidropiranil-amino-pirrolopirimidinon felhasználásra BTK-által közvetített zavarok kezelésében | |
| HUE053763T2 (hu) | Immunellenõrzésipont-gátlók véreredetû rákok kezelésében történõ alkalmazásra | |
| PL3157512T3 (pl) | Zastosowanie kannabidioli w leczeniu padaczki | |
| SI3240554T1 (sl) | Blautia stercosis in wexlerae za uporabo v zdravljenju vnetnih in avtoimunskih bolezni | |
| PL3503890T3 (pl) | Stosowanie pridopidyny w leczeniu dystonii | |
| EP3564335A4 (en) | SURFACE TREATMENT AGENT | |
| DK3481846T3 (da) | 11-substituerede 24-hydroxysteroler til anvendelse til behandling af nmda-relaterede tilstande | |
| PL3186244T3 (pl) | Analogi dioksolanowe urydyny w leczeniu raka | |
| EP3409744A4 (en) | SURFACE TREATMENT AGENT | |
| EP3334429C0 (en) | HYPERPHENYLALANINEMIA AND TREATMENTS THEREFOR | |
| EP3508550A4 (en) | POLISHING COMPOSITION AND POLISHING COMPOSITION ASSEMBLY | |
| PL3773715T3 (pl) | Mirikizumab w leczeniu wrzodziejącego zapalenia jelita grubego | |
| EP3431566A4 (en) | SURFACE TREATMENT AGENT | |
| PL3490560T3 (pl) | Niraparyb do stosowania w sposobie leczenia nowotworu prostaty | |
| DK3374497T3 (da) | Modificerede makrofager til anvendelse i behandlingen af kræft | |
| HUE058314T2 (hu) | Pridopidin alkalmazása Rett-szindróma kezelésére | |
| PL3236960T3 (pl) | Fluralaner do zastosowania w leczeniu demodekozy | |
| DK3164123T3 (da) | Hidtil ukendte anvendelser af benzylidenguanidinderivater til behandling af proteopatier | |
| DK3532067T3 (da) | Liposomal formulering til anvendelse til behandling af cancer | |
| PL3432872T3 (pl) | Eflornityna do zastosowania w leczeniu nawracającego/opornego na leczenie temozolomidem gwiaździaka anaplastycznego | |
| PL3732294T3 (pl) | Tymohydrochinon do stosowania w leczeniu hiperglikemii | |
| HUE053927T2 (hu) | Farneziltranszferáz inhibitorok rák kezelésében történõ alkalmazásra |